Presented at European Association of Dermato Oncology (EADO) 2018
Collaborator: Pierre Fabre
Authors: Basset Seguin N, Malvehy J, Ulianov L, Condomines M, Beauchamp R, Dos Santos R
While organ transplants greatly improve patients’ quality of life, transplant patients must nonetheless take immunosuppressive drugs to prevent organ rejection. Thus, new risks emerge, including a higher chance of developing non-melanoma skin cancer (NMSC). The objectives of the study were to describe characteristics of patients with and without skin lesions and to better understand the skin monitoring after organ transplant.